Without fanfare, the U.S. Centers for Disease Control and Prevention, August 11, 2022, reversed all its COVID-19 guidelines. In fact, many have noted it appears the CDC wanted to bring as little attention to it as possible.1 This is understandable, considering the new guidelines more or less admit the original rules were in error, without… Read More »
Appearing at a televised town-hall-style meeting in Ohio last week, President Joe Biden said that emergency clearance for paediatric vaccines would come “soon.” The White House has declined to be more specific on the timeline, and it was unclear whether expanding the studies will have any effect on when vaccines could be authorised for children.… Read More »
A researcher whose work has focused on the effect MDMA has on behaviour has questioned the “hyped up” findings from research into psychedelics potential to treat PTSD. Melbourne University researcher Dr Gillinder Bedi said the small number of participants in current trials likely skew results and federal funding would be best directed towards sizing up.… Read More »
In a new report published by the Brookings Institution, Matthew Fiedler, Ph.D. ’13 , a fellow in economic studies at the USC-Brookings Schaeffer Initiative for Health Policy, and Zirui Song, M.D. ’10, Ph.D. ’12, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, estimate national health care spending for COVID-19 care and… Read More »
The volunteers at the University of Chicago’s Brain Dynamics Laboratory, all otherwise young and healthy, were tied together by really only one thing: nearly off-the-chart scores on the most widely used scale measuring loneliness. Asked how often they felt they had no one they could turn to, how often they felt their relationships seemed superficial… Read More »